USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
His most recent stint was with Danone India as its Managing Director
10+ emerging markets, Japan & ANZ transition in final phase
The product will be manufactured at Lupin's Pithampur facility in India
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Subscribe To Our Newsletter & Stay Updated